US · Healthcare

Cbd of Denver Inc (CBDD)

Drug Manufacturers - Specialty & Generic

Cbd of Denver Inc (CBDD) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CBDD

P/E ratio

18.00

Cbd of Denver Inc (CBDD) — FAQ

What is CBDD's P/E ratio?

The price-to-earnings (P/E) ratio for Cbd of Denver Inc (CBDD) is 18.00 (data as of 2026-03-23).

Does Cbd of Denver Inc pay a dividend?

Dividend yield is not available in the current snapshot for Cbd of Denver Inc (CBDD). Check the MyAverix Finance app for the latest dividend data.

What sector is Cbd of Denver Inc in?

Cbd of Denver Inc (CBDD) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is CBDD listed on?

CBDD is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)